Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4345-4349

  Al Jameil Dr, Noura ^a   Khan, Farah A ^a   Arjumand, Sadia ^a   Khan, Mohammad F ^a   Tabassum, Hajera ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

ALT; AST; Diabetes; Dyslipidemia; GGT

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANALYSIS; ENZYMOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 84906217858     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ikekpeazu EJ, Neboh EE, Maduka IC, Nwagbar IJ, Nwobodo MW. Type-2 diabetes mellitus and malaria parasitaemia: Effect on liver function tests. As J Med Sci 2010; 2: 214-217.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Geneva: World Health Organization; 1999.
3. Jin H, Gu Z, Yu C, Li Y. Association of non-alcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. Hepatobiliary Pancreat Dis Int 2005; 4: 389-392.
4. Clouston A, Powell E. Nonalcoholic fatty liver disease: Is all the fat bad? Intern Med J 2004; 34: 187-191.
5. Hanley AJ, Williams K, Festa A, Wagenknecht LE, Kempf J, ZinmanB, Haffner SM. Elevations in marker of liver injuryand risk of type 2 diabetes-The insulin resistance atherosclerosis study. Diabetes 2004; 53: 2623-2632.
6. Lee DH, Silventonein K, Jacobs DR, Jousilhati P, Tuomileto J. Gamma glutamyltransferase, obesity and the risk of type 2 diabetes observational cohort study among 20,158 middle aged men and women. J Clin Endocrinol Metab 2014; 89: 5410-5414.
7. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR. Gamma glutamyltransferase and diabetes-a four year follow up study. Diabetologia 2003; 46: 359-364.
8. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007; 30: 734-743.
9. Harris EH. Elevated liver function tests in type2 diabetes. Clin Diab 2005; 23: 115-119.
10. Balaji AS. Serum alanine transaminases and lipid profile in type 2 diabetes mellitus Indian patient. J Diab Res 2014; [Epub ahead of print].
11. Jameil NA, Khan FA, Arjumand S, Khan MF, Tabassum H. Biomedical Res 2014; 25.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma. Clin Chem 1972; 18: 499-502.
13. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem 1986; 32: 64-70.
14. Nwarfor A, Owhoji A. The prevalence of diabetes mellitus in port-Harcourt correlates with the socio-economic status. J Appl Sci Environ Mgt 2001; 5:75-77.
15. Saligram S, Williams EJ, Masding MG. Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycemic control. Ind J Endocrin Metab 2012; 16: 1012-1014.
16. Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo PP, PaciniG, Rizzetto M, Pagano G. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 2001; 36: 1117-1124.
17. Odewabi AO, Akinola EG, Ogundahunsi OA, Oyegunle VA, Amballi AA, Raimi TH, Adeniyi FA. Liver Enzymes and its Correlates in Treated and Newly Diagnosed Type 2 Diabetes Mellitus Patients in Osogbo, South West, Nigeria. Asian J Med Sci 2013; 5: 108-112.
18. Han N, Soe HK, Htet A. Determinants of Abnormal Liver Function Tests in Diabetes Patients in Myanmar. Int J Diab Res 2012; 1: 36-41.
19. Adeniran SA, Dolapo PO, Oluwole AB, Temitope A, Niran A, Ahmed KJ. Liver Enzymes and Lipid Profile Among Type 2 Diabetic Patients in Osogbo, Nigeria. Greener J Med Sci 2013; 3: 174-178.
20. Idris AS, Mekky FH, Abdalla EE, Ali KA. Liver function tests in type 2 Sudanese diabetic patients. Int J Nutr Metab 2011; 3: 17-21.
21. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E. Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study. Diabetes Care 2005; 28: 1757-1762.
22. Jayarama N, Sudha R. A study of non-alcoholic fatty liver disease (NAFLD) in type2 diabetes mellitus in a tertiary care centre, Southern India. J Clin Diag Res 2012; 6: 243-245.
23. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O. Liver function tests in diabetic patients. Diabetes Care 1984; 7: 248-254.
24. Tolman KG, Fonseca V, Tan MH, Dalpiaz A. Hepatobiliary disease in type 2 diabetes mellitus. Ann Intern Med 2004; 141: 946-956.
25. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenesis in adults with diabetes. Med Balt 1996; 75: 327-333.
26. Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, DallAE, Dalle GR, Morpurgo PS, Tomasi F, Vitacolonna E. Aminotransferase and gammaglutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005; 28: 333-339.
27. Cho NH, Lee HK, Jang HC, Choi SE, Kim HR. Abnormal liver function test predicts type 2 diabetes. Diabetes Care 2007; 30: 2566-2568.
28. Nakanishi N, Suzuki K, Tatara K. Serum gamma glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle aged Japanese men. Diabetes Care 2004; 27: 1427-1432.
29. Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE. Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358-1366.
30. Sakuta H, Suzuki T, Yasuda H, Ito T. Gamma glutamyltransferase and airflow obstruction in middle-aged men. Eur J Intern Med 2005; 16: 348-351.
31. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. High alanine amino transferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 1889-1895.
32. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
33. Marchesini G, Forlani G. NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002; 35: 497-499.
34. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986; 21: 109-113.
35. Ahn HR, Nam HS, Park KS, Lee YH, Jeong SK, Choi JS, Kweon SS. The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetol Metab Syndr 2014; 6: 14.
36. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 290: 3000-3004.
37. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-967.